Neurosarcoidosis
CNS sarcoidosis · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Granulomatous inflammation of the nervous system occurring in a minority of patients with sarcoidosis, presenting variably with cranial neuropathy (classically facial palsy), meningitis, myelopathy or hypothalamic-pituitary dysfunction. Diagnosis is challenging and treatment is immunosuppressive.
Red flags
- Rapid neurological deterioration or cord compression
- Hydrocephalus from basal meningitis
- Hypothalamic-pituitary failure (adrenal crisis, diabetes insipidus)
- Undiagnosed TB mimicking sarcoid
- Visual loss from optic neuropathy
Assessment
Differential diagnosis
- Multiple sclerosis and other demyelination
- Tuberculous or other chronic meningitis
- CNS lymphoma
- Vasculitis
- Behcet's disease
- Idiopathic cranial neuropathy
Investigations
- MRI brain and spine with contrast (leptomeningeal enhancement, parenchymal lesions)
- CSF analysis (lymphocytic pleocytosis, raised protein, oligoclonal bands, raised ACE)
- Serum ACE and calcium (insensitive)
- CT chest / PET to find systemic disease and a biopsy target
- Tissue biopsy (extra-neural if possible) showing non-caseating granulomas
- Exclude TB and infection before immunosuppression
Management
- Suspect neurosarcoidosis in subacute cranial neuropathy, aseptic meningitis or myelopathy
- Seek systemic sarcoidosis (chest imaging, PET) to obtain accessible biopsy confirmation
- Perform MRI with contrast and CSF analysis
- Rigorously exclude infection, especially TB, before immunosuppression
- Start corticosteroids as first-line therapy for active disease
- Add a steroid-sparing immunosuppressant for relapsing or steroid-dependent disease
- Use TNF-alpha inhibitors (infliximab) for refractory disease
- Monitor and manage endocrine dysfunction from hypothalamic-pituitary involvement
- Treat seizures and other symptomatic complications
- Taper steroids slowly with specialist follow-up
Drugs & doses
Prednisolone 0.5-1 mg/kg PO daily, tapering over months
Methylprednisolone 1 g IV daily for 3-5 days for severe presentations
Methotrexate 10-25 mg PO/SC weekly (steroid-sparing)
Azathioprine or mycophenolate as alternatives
Infliximab 5 mg/kg IV infusion for refractory disease
Disposition
Specialist neurology with respiratory/sarcoidosis multidisciplinary input. Admission for severe presentations. Long-term immunosuppression monitoring.
Complications & pitfalls
- Permanent neurological deficit
- Hydrocephalus
- Hypopituitarism and endocrine failure
- Immunosuppression-related infection
- Relapse on steroid withdrawal
Exam pearls
- Facial nerve palsy is the classic cranial neuropathy in neurosarcoidosis
- Always exclude TB before immunosuppressing granulomatous CNS disease
- Biopsy of accessible systemic disease avoids risky neural biopsy
- Serum ACE is neither sensitive nor specific; do not rely on it
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.